Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made in obtaining the full validation of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative to predict the proarrhythmic potential of new drugs.

The strategy has not committed to obtaining the full validation of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative to predict the proarrhythmic potential of new drugs.

Basket 2 of the strategy outlines long‑term ambitions which must be science‑led, partnership‑based, and delivered over time.

The strategy aims to use validated alternative methods to reduce the use of dogs and non-human primates in dedicated Pharmacokinetic studies for human medicines by at least 35% by 2030.